Country Grants

 

Having worked extensively with countries through Fleming Fund Global Grants and partners such as the World Health Organization (WHO), the Food and Agriculture Organization (FAO) and the World Organisation for Animal Health (OIE); the Fleming Fund has also begun deepening this engagement and partnership with countries, in order to offer Country Grants that can support key activities from antimicrobial resistance (AMR) national action plans relating to improving AMR surveillance.

By 2022, the Fleming Fund will have helped 24 low and middle income countries to put in place the building blocks of a sustainable national surveillance programme for antimicrobial resistance and for monitoring of antimicrobial use in human and animal health. As a consequence of this investment, we expect to see an increase in high quality data that is shared nationally and globally, and that this will form the basis of changes in policy and practice for the use of antimicrobial medicines.

The Fleming Fund Country Grants programme will assist countries to collect relevant high quality data on the problem of antimicrobial resistance and drug resistant infections, and on the use of antimicrobial medicines in human and animal health, in agriculture and aquaculture, and in the environment. To learn more about Fleming Fund Country Grants click here, or see the FAQs below. 

 

Why focus on surveillance?

As the Fleming Fund is one of the largest international aid investments dedicated to improving AMR surveillance, the most cost-effective contribution we can make is to support countries to begin to implement global recommendations on surveillance, such as GLASS. This is because:

  • Countries need robust surveillance data on AMR and the use of antimicrobials in order to make informed decisions on their priorities and allocate (often scarce) resources to tackle AMR. Good quality surveillance data is therefore key to delivering effective national responses to AMR.

  • Effective policy, practice and investment needs to be guided by evidence. In the case of AMR, such evidence can only be generated through robust and functional surveillance programmes collecting representative data.

  • A sustainable and effective surveillance system will have the ability to monitor trends in resistance, prevalence, and the consumption and use of antibiotics and allow better decision making. This data can only be provided through effective national surveillance networks.

  • A functional surveillance system can be used to detect and alert authorities to new types of resistance and help to identify outbreaks of resistant infections which are of concern to health security.

Through Fleming Fund Country Grants, we therefore aim to help countries generate the data that will drive and sustain national and global investment in AMR.

One Health is one of the four principles governing Fleming Fund investments.  Data on resistance and use of antimicrobials in human health, animal health, agriculture and aquaculture, and presence in the environment are all important factors in the threat of AMR to public health.

 

What and who can be funded?

The Fleming Fund Country Grants programme will prioritise 24 countries that meet the right criteria on capability, risk and context. All grants and awards must observe the principles of country ownership, One Health, strategic alignment and sustainability.

Country Grants will be used to support key priorities around surveillance identified in national action plans. These grants can be used for five main investment areas:

  • Laboratory infrastructure enhancement

  • Capacity building

  • Strengthening surveillance systems

  • Improved AMR data use

  • Promoting the rational use of antimicrobial medicines 

Grants will be awarded competitively following a published request for proposals. The Fleming Fund management grant for Country Grants will engage with countries through a phased approach. Request for proposals will be published as they are ready. The request for proposals will be developed hand-in-hand with national AMR Coordination Committees after a detailed needs assessment.

Grant packages will be tailored to the specific needs of the country. Applicants should note that the fund cannot make financial disbursements directly to governments. Application toolkits and guidelines can only be obtained directly from the management agent, Mott MacDonald, after the request for proposals is published.

Current Country Grant RFPs Status

Nepal – Applications closed 31 January 2018
Ghana – Applications closed 13 February 2018
Uganda – Applications closed 14 March 2018
Bhutan – Grant in development with Royal Government of Bhutan

 

Request for Proposals – Laos, now open

Please find below the link to the Request for Proposals (RFP) document for a Country Grant to support AMR and AMU surveillance in Laos.

Mott MacDonald, the Fleming Fund Management Agent for Country Grants, invites proposals from qualified licenced/registered entities in Laos to work toward strengthening AMR and AMU surveillance in Laos, in collaboration with the Government of Lao PDR’s Antimicrobial Resistance Surveillance and Control Committee (ASCC), otherwise known as the AMR Committee.

Download RFP here

Please note the key dates for the RFP, including the need to register interest to apply for the grant by 12 June 2018.

  • Publication of RFP: 22 May 2018
  • Registration to apply for the grant is open between 22 May and 12 June 2018.
  • Deadline for registering interest to attend the Applicant Information Session: 4 June 2018 17.00 ICT (GMT+7).
  • Applicant Information Session: 11 June 2018 – time TBC, Vientiane
  • Deadline for registering interest to receive the official Application Pack: 12 June 2018 17.00 ICT (GMT+7).
  • Application submission deadline: 20 July 2018 17.00 ICT (GMT+7).
  • Anticipated start date of grant: 1 October 2018.

In the event of problems downloading the RFP, please request it from flemingfundSEA@mottmac.com.

The Fleming Fund Country Grants are delivered by Mott MacDonald